glp 1 cigna coverage for glp-1 Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss Cigna Wins First Cir. Bias

Thanks for your time

Microscopic venous invasion is associated with a higher risk of recurrence and worse prognosis in cases such as pediatric adrenal cortical tumors, hepatocellular carcinomas, pancreatic cancers, and pancreatic neuroendocrine tumors [12,13,14,15]

However, further studies are required to establish their role in patient stratification and clinical decision-making

Pappas in the Journal of Vascular Surgery: Venous and Lymphatic Disorders found that treatment outcomes for chronic venous disease improve as BMI decreases, and that higher BMI is independently associated with poorer results after venous procedures